MANIFESTASI KLINIS DAN TATALAKSANA OPERATIF DEGENERASI KORNEA NODULAR SALZMANN
DOI:
https://doi.org/10.11594/ojkmi.v5i1.45Keywords:
AMT, cornea, keratectomy, Salzmann's nodular degenerationAbstract
Introduction: Salzmann nodular degeneration (SND) is an idiopathic and degenerative noninflammatory condition of the cornea. SND is characterized by a grayish-white or blue-white subepithelial nodule. Mild symptoms may improve with lubrication and topical anti-inflammatory therapy. Visual disturbances may occur and surgery may be required.
Purpose: To explain clinical manifestations and operative management of corneal Salzmann nodular degeneration.
Case Report: A 63-year-old woman came with the chief complaint of a nodule in her left eye since 4 months ago. Complaints accompanied by blurry vision, watery eyes and glare. Ophthalmological examination revealed a regression of visual, a nodule in the corneal stroma was grayish white. After examination, the patient was diagnosed with Salzmann OS nodular degeneration and ODS immature senile cataract. Debridement keratectomy and amniotic membrane transplantation (AMT) were performed as the management of this patient. Anatomical pathology results clinically support Salzmann's nodular degeneration.
Discussion: Slow-progressive, yellowish-white nodules are characteristic of SND. SND can be asymptomatic, mild symptoms, or until there is a decrease in visual function. It depends on the location and depth of the nodule. Several treatment options can be done ranging from conservative with topical drugs to surgery. Surgical treatment options have the goal of reducing the worsening symptoms of nodule recurrence.
Conclusions: A complete history, comprehensive ophthalmological examination can help establish the diagnosis of SND. The appearance of nodules causes complaints of foreign body sensation, decreased visual function and other accompanying symptoms. Treatment needs to be given according to the patient's condition and indications, especially the selection of surgical therapy.
Downloads
References
Feder RS, Berdy G, Iuorno JD. External Disease and Cornea. In: Basic and Clinical Science Course. American Academy of Ophthalmology; 2021. hlm. 169–70.
Brown CA, Natanell N. Salzmanns Nodular Corneal Degenaeration [Internet]. StatPearls Publishing. 2021. [diunduh 12 Juli 2022]. Tersedia dari : https://www.ncbi.nlm.nih.gov/-books/NBK560684/
Garg P, Sharma A, Khan M. Salzmann’s Nodular Degeneration Right Eye - A Case Report. J Med Sci Clin Res. 2019;07(06). hlm. 860–3.
Paranjpe V, Galor A, Monsalve P, Dubovy SR, Karp CL. Salzmann nodular degeneration: prevalence, impact, and management strategies. Clin Ophthalmol. 2019;13. hlm. 1305-14.
Monaco G, Casalino G. Superficial keratectomy followed by intense pulsed light for Salzmann’s nodular degeneration and coexisting meibomian gland dysfunction. Eur J Ophthalmol. 2020. hlm. 1–4.
Goerlitz-Jessen MF, Gupta PK, Kim T. Impact of epithelial basement membrane dystrophy and Salzmann nodular degeneration on biometry measurements. J Cataract Refract Surg. 2019 Aug;45(8). hlm 1119-23.
Hopping GC, Somani AN, Vaidyanathan U, Liu H, Barnes JR, Ronquillo YC, dkk. Myopic regression and recurrent Salzmann nodule degeneration after laser in situ keratomileusis in Ehlers Danlos Syndrome. Am J Ophthalmol Case Rep. 2020 Sep;19:100729.
He X, Donaldson KE. Superficial keratectomy for Salzmann nodular degeneration following laser in situ keratomileusis. Can J Ophthalmol. 2019 Jun;54(3). hlm. 159-151.
Bell K, de Padua Soares Bezerra B, Mofokeng M, Montesano G, Nongpiur ME, Marti MV, dkk. Learning from the past: Mitomycin C use in trabeculectomy and its application in bleb-forming minimally invasive glaucoma surgery. Surv Ophthalmol. 2021 Jan - Feb;66(1). hlm. 109-123.
Cheng AM., Tseng SC. Removal of Salzmann’s nodule and amniotic membrane replacement. In: Operative Dictations in Ophthalmology. Springer; 2017. hlm. 71–4.
Downloads
Submitted
Accepted
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Oftalmologi: Jurnal Kesehatan Mata Indonesia

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.